26.12.2013 Views

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

causing <strong>the</strong> increased leakage <strong>of</strong> electrons gener<strong>at</strong>ed by <strong>the</strong> oxid<strong>at</strong>ive phosphoril<strong>at</strong>ion<br />

process. These electrons will rapidly react with molecular oxygen producing reactive<br />

oxygen species (ROS) (Gille and Nohl 1997). Ano<strong>the</strong>r p<strong>at</strong>hway <strong>of</strong> adriamycin-induced<br />

apoptosis was described in isol<strong>at</strong>ed adult cardiac myocytes (Andrieu-Abadie et al.1999;<br />

Henaff et al. 2002). Adriamycin has a potential tp activ<strong>at</strong>e acidic sphlingomyelinase<br />

which will result in <strong>the</strong> increased production <strong>of</strong> ceramide (Andrieu-Abadie et al. 1999).<br />

The increase in <strong>the</strong> intracellular levels <strong>of</strong> ceramide will lead to <strong>the</strong> activ<strong>at</strong>ion <strong>of</strong><br />

mitochondrial membrane voltage-independent B type calcium charmels which will result<br />

in <strong>the</strong> opening <strong>of</strong> mitochondrial transition pores and release <strong>of</strong> cytochrome C (Andrieu-<br />

Abadie et al. 1999). This hypo<strong>the</strong>sis is confirmed by <strong>the</strong> reports th<strong>at</strong> carnitine, an<br />

inhibitor <strong>of</strong> acid sphl'ngomyelinase, has a potential to inhibit adriamycin-induced<br />

apoptosis.<br />

Adriamycin administr<strong>at</strong>ion was also found to cause <strong>the</strong> activ<strong>at</strong>ion <strong>of</strong> proapoptotic<br />

factor-p38 mitogen activ<strong>at</strong>ed protein kinases (MAPK), while <strong>the</strong> inhibitors <strong>of</strong> p38 MAPK<br />

were found to prevent <strong>the</strong> occurrence <strong>of</strong> adriamycin-induced apoptosis in cardiac<br />

myocytes (Kang et al. 2000b). Adriamycin-induced activ<strong>at</strong>ion <strong>of</strong> p38 was prevented by a<br />

cardiac-specific overexpression <strong>of</strong> antioxidant compounds met<strong>at</strong>allothioenins thus linking<br />

<strong>the</strong> adriamycin-induced oxid<strong>at</strong>ive stress with p38 initi<strong>at</strong>ed apoptosis in cardiac myocytes<br />

(Kang et al. 2000b).<br />

The involvement <strong>of</strong> oxid<strong>at</strong>ive stress in <strong>the</strong> p<strong>at</strong>hogenesis <strong>of</strong> adriamycin-induced<br />

apoptosis in isol<strong>at</strong>ed cardiac myocytes was also confirmed in a study where tre<strong>at</strong>ments<br />

with antioxidant trolox prevented <strong>the</strong> development <strong>of</strong> adriamycin-induced apoptosis<br />

(Kumar et al. 1999). It is interesting to mention th<strong>at</strong> <strong>the</strong> exposure <strong>of</strong> isol<strong>at</strong>ed cardiac<br />

t5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!